STAT+: Bristol Myers agrees to pay $75 million to settle allegations of underpaying Medicaid rebates
After years of litigation, Bristol-Myers Squibb (BMY) agreed to pay $75 million, plus interest, to resolve allegations of knowingly underpaying rebates that were owed to state Medicaid programs.
The settlement, which the company had signaled a year ago was in the works, stems from a whistleblower lawsuit filed in 2013 by the former head of a health care industry trade group who had filed similar suits against several drug makers.
Continue to STAT+ to read the full story…
